Home > Boards > US OTC > Miscellaneous > Therapeutic Solutions International, Inc. (TSOI)

you're right, the graph is very clear

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
corvatsch Member Profile
 
Followed By 5
Posts 333
Boards Moderated 0
Alias Born 12/11/13
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2019 4:28:47 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/13/2019 1:46:36 PM
Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients InvestorsHub NewsWire - 8/5/2019 9:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/30/2019 4:44:49 PM
NanoStilbene™ Nutraceutical Shown to Increase Ability of Cyclophosphamide Chemotherapy to Suppress Cancer InvestorsHub NewsWire - 7/29/2019 9:00:00 AM
Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Ca... InvestorsHub NewsWire - 7/22/2019 9:00:00 AM
Therapeutic Solutions International adds Nano Cannabidiol to NanoMyros for Inhibition of Microvesicle and Exosome Release InvestorsHub NewsWire - 7/15/2019 9:00:00 AM
Therapeutic Solutions International Develops Adjuvant Technology to Enhance Prostate Cancer Suppressing Properties of InvestorsHub NewsWire - 7/11/2019 9:00:00 AM
Therapeutic Solutions International Develops Glucoraphanin + NanoStilbene Encapsulated product InvestorsHub NewsWire - 7/8/2019 9:00:00 AM
Therapeutic Solutions International Obtains Exclusive License for Patented Clinical Stage Adult Stem Cell for Treatment of InvestorsHub NewsWire - 7/1/2019 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2019 11:12:46 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/20/2019 11:18:31 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/14/2019 11:22:33 AM
Therapeutic Solutions International Awards Distribution of NanoStilbene and Nano Cannabidiol in Mexico to Immun ET Laboratori... InvestorsHub NewsWire - 5/6/2019 9:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/15/2019 1:36:47 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 3/29/2019 11:33:18 AM
Therapeutic Solutions International Continues to Refine NanoStilbene™ Formulation InvestorsHub NewsWire - 2/19/2019 9:00:00 AM
Therapeutic Solutions International Continues to Expand Chronic Traumatic Encephalopathy Intellectual Property Portfolio InvestorsHub NewsWire - 1/22/2019 9:00:00 AM
Therapeutic Solutions International Announces Preliminary Data for Immune Stimulation in Advanced Cancer Patients InvestorsHub NewsWire - 1/14/2019 9:00:00 AM
Therapeutic Solutions International Continues to Expand Chronic Traumatic Encephalopathy Intellectual Property Portfolio InvestorsHub NewsWire - 1/9/2019 11:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/8/2019 4:29:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/8/2019 4:24:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/8/2019 4:17:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2019 4:01:34 PM
Therapeutic Solutions International CEO Issues Shareholder Letter InvestorsHub NewsWire - 12/31/2018 9:00:00 AM
corvatsch   Wednesday, 08/14/19 11:09:10 AM
Re: NoMoDo post# 11922
Post # of 11999 
you're right, the graph is very clear
the level of 0.0025 is important, without new important news the return to the area 0.0011-0.0015 is very likely (September)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist